Recro Pharma, Inc.·4

Dec 18, 2:24 PM ET

Recro Pharma, Inc. 4

4 · Recro Pharma, Inc. · Filed Dec 18, 2015

Insider Transaction Report

Form 4
Period: 2015-12-16
Mack Randall
Senior VP, Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2015-12-16+20,00020,000 total
    Exercise: $8.41Exp: 2025-12-16Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT